JP2003505422A5 - - Google Patents

Download PDF

Info

Publication number
JP2003505422A5
JP2003505422A5 JP2001511940A JP2001511940A JP2003505422A5 JP 2003505422 A5 JP2003505422 A5 JP 2003505422A5 JP 2001511940 A JP2001511940 A JP 2001511940A JP 2001511940 A JP2001511940 A JP 2001511940A JP 2003505422 A5 JP2003505422 A5 JP 2003505422A5
Authority
JP
Japan
Prior art keywords
composition
hyaluronic acid
site
growth
bone growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001511940A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003505422A (ja
Filing date
Publication date
Priority claimed from US09/360,543 external-priority patent/US6221854B1/en
Application filed filed Critical
Publication of JP2003505422A publication Critical patent/JP2003505422A/ja
Publication of JP2003505422A5 publication Critical patent/JP2003505422A5/ja
Pending legal-status Critical Current

Links

JP2001511940A 1999-07-26 2000-07-26 ヒアルロン酸と成長因子を用いた骨成長促進方法 Pending JP2003505422A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/360,543 1999-07-26
US09/360,543 US6221854B1 (en) 1996-03-05 1999-07-26 Method of promoting bone growth with hyaluronic acid and growth factors
PCT/US2000/020373 WO2001007056A1 (en) 1999-07-26 2000-07-26 Method of promoting bone growth with hyaluronic acid and growth factors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009030095A Division JP2009143949A (ja) 1999-07-26 2009-02-12 ヒアルロン酸と成長因子を用いた骨成長促進方法

Publications (2)

Publication Number Publication Date
JP2003505422A JP2003505422A (ja) 2003-02-12
JP2003505422A5 true JP2003505422A5 (cg-RX-API-DMAC7.html) 2012-06-07

Family

ID=23418431

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001511940A Pending JP2003505422A (ja) 1999-07-26 2000-07-26 ヒアルロン酸と成長因子を用いた骨成長促進方法
JP2009030095A Pending JP2009143949A (ja) 1999-07-26 2009-02-12 ヒアルロン酸と成長因子を用いた骨成長促進方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009030095A Pending JP2009143949A (ja) 1999-07-26 2009-02-12 ヒアルロン酸と成長因子を用いた骨成長促進方法

Country Status (7)

Country Link
US (3) US6221854B1 (cg-RX-API-DMAC7.html)
EP (1) EP1198235A4 (cg-RX-API-DMAC7.html)
JP (2) JP2003505422A (cg-RX-API-DMAC7.html)
AU (1) AU777328B2 (cg-RX-API-DMAC7.html)
CA (1) CA2378328A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ516097A (cg-RX-API-DMAC7.html)
WO (1) WO2001007056A1 (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221854B1 (en) * 1996-03-05 2001-04-24 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
US20110207666A1 (en) * 1996-03-05 2011-08-25 Depuy Spine, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
US20050043234A1 (en) * 1996-10-16 2005-02-24 Deisher Theresa A. Novel FGF homologs
US6722054B2 (en) 1998-11-12 2004-04-20 Atrix Laboratories, Inc. Process and delivery container for lyophilizing active agent
US6907679B2 (en) * 1998-11-12 2005-06-21 Qlt Usa, Inc. Method for lyophilizing an active agent
US6566144B1 (en) * 2000-03-27 2003-05-20 Atrix Laboratories Cover plate for use in lyophilization
CA2445239C (en) * 2001-04-25 2012-08-21 Eidgenossische Technische Hochschule Zurich Drug delivery matrices to enhance wound healing
US7008626B2 (en) * 2001-11-05 2006-03-07 Seikagaku Corporation Medical composition for protuberance of epithelium
US7247609B2 (en) * 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
IL149562A0 (en) 2002-05-09 2002-11-10 Prochon Ltd Fgf variants and methods for use thereof
US7842300B2 (en) * 2002-07-31 2010-11-30 Dentsply International, Inc. Bone repair putty
US8876532B2 (en) 2002-07-31 2014-11-04 Dentsply International Inc. Bone repair putty
EP1551426B1 (en) * 2002-10-07 2014-06-25 ZymoGenetics, Inc. Methods of administering fgf18
WO2004062588A2 (en) * 2003-01-06 2004-07-29 University Of Utah Water-soluble polymeric bone-targeting drug delivery system
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
FR2866571B1 (fr) * 2004-02-20 2007-09-21 Philippe Zanchetta Utilisation d'un melange de polysaccharides specifiques denomme par l'inventeur ezbone, comprenant de l'acide hyaluronique, de la chondroitine 6 sulfate, du dermatane sulfate et de l'heparine en cicatrisation osseuse.
WO2006014444A1 (en) 2004-07-06 2006-02-09 Zymogenetics, Inc. Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20090319045A1 (en) 2004-10-12 2009-12-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
AU2005318097A1 (en) * 2004-12-22 2006-06-29 Kuros Biosurgery Ag Michael-type addition reaction functionalised peg hydrogels with factor XIIIA incorporated biofactors
WO2006073711A2 (en) * 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
WO2006072622A2 (en) * 2005-01-06 2006-07-13 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
US8575101B2 (en) 2005-01-06 2013-11-05 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
KR20080080481A (ko) * 2005-09-02 2008-09-04 콜바르 라이프사이언스 리미티드 교차-결합된 다당류 및 단백질 매트릭스 및 그의 제조 방법
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
US20080255041A1 (en) * 2007-04-11 2008-10-16 Ebi, L.P. Treatment of annulus fibrosis defects
US20090054984A1 (en) 2007-08-20 2009-02-26 Histogenics Corporation Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
US8685107B2 (en) 2007-07-03 2014-04-01 Histogenics Corporation Double-structured tissue implant and a method for preparation and use thereof
US20090023631A1 (en) * 2007-07-18 2009-01-22 Lorenc Z Paul Composition and Method of Use for Soft Tissue Augmentation/Drug Delivery
RU2501811C2 (ru) * 2007-11-13 2013-12-20 Био-Текнолоджи Дженерал (Изрейел) Лтд. Способ стерилизации посредством фильтрации разбавленных вязкоэластичных биополимеров (варианты)
ES2882852T3 (es) 2011-03-16 2021-12-02 Kuros Biosurgery Ag Formulación farmacéutica para la utilización en la fusión espinal
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
UA122170C2 (uk) 2016-02-05 2020-09-25 Толмар Терапьютікс, Інк. Вентильована покривна пластина для масиву шприців
WO2019006113A1 (en) * 2017-06-28 2019-01-03 Rutgers, The State University Of New Jersey ORGANOIDS DERIVED FROM A SINGLE CEREBRAL CELL
US11834680B2 (en) 2017-06-28 2023-12-05 Rutgers, The State University Of New Jersey Single kidney cell-derived organoids
USD908916S1 (en) 2018-06-19 2021-01-26 Tolmar Therapeutics, Inc. Syringe restrictor plate
US12667594B2 (en) 2020-05-04 2026-06-30 Vivex Biologics Group, Inc. Hyaluronic composition

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472840A (en) 1981-09-21 1984-09-25 Jefferies Steven R Method of inducing osseous formation by implanting bone graft material
US4394370A (en) 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
US4409332A (en) 1982-01-12 1983-10-11 Jefferies Steven R Collagen-enzyme conjugates that exhibit no inflammatory response and method for making the same
US5166331A (en) 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
IT1212892B (it) * 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
US5128326A (en) 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US5133755A (en) * 1986-01-28 1992-07-28 Thm Biomedical, Inc. Method and apparatus for diodegradable, osteogenic, bone graft substitute device
US6005161A (en) * 1986-01-28 1999-12-21 Thm Biomedical, Inc. Method and device for reconstruction of articular cartilage
US5283255A (en) 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
JPH02213A (ja) 1987-10-19 1990-01-05 Taiho Yakuhin Kogyo Kk 生理活性ペプチド持続製剤
GB2215209B (en) * 1988-03-14 1992-08-26 Osmed Inc Method and apparatus for biodegradable, osteogenic, bone graft substitute device
JP2820415B2 (ja) * 1988-03-14 1998-11-05 ティーエイチエム・バイオメディカル・インコーポレイテッド 生分解性および骨形成性を有する移植骨片代用組成体
US5354557A (en) 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5100668A (en) 1988-06-14 1992-03-31 Massachusetts Institute Of Technology Controlled release systems containing heparin and growth factors
US5202311A (en) 1988-08-19 1993-04-13 Children's Medical Center Corporation Stabilized fgf composition
US5470829A (en) * 1988-11-17 1995-11-28 Prisell; Per Pharmaceutical preparation
US5013714A (en) 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
US5130418A (en) 1989-05-02 1992-07-14 California Biotechnology Inc. Method to stabilize basic fibroblast growth factor
US5077049A (en) 1989-07-24 1991-12-31 Vipont Pharmaceutical, Inc. Biodegradable system for regenerating the periodontium
WO1991001720A1 (en) 1989-08-07 1991-02-21 Herman Wade Schlameus Composition and method of promoting hard tissue healing
US5030457A (en) 1989-08-28 1991-07-09 Pharmaceutical Delivery Systems, Inc. Bioerodible polymers useful for the controlled release of therapeutic agents
US5422340A (en) 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
US5158934A (en) 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
US5236456A (en) * 1989-11-09 1993-08-17 Osteotech, Inc. Osteogenic composition and implant containing same
US5217954A (en) 1990-04-04 1993-06-08 Scios Nova Inc. Formulations for stabilizing fibroblast growth factor
US5425769A (en) 1990-04-23 1995-06-20 Snyders, Jr.; Robert V. Composition of material for osseous repair
DK0532546T3 (da) 1990-05-10 1998-12-28 Nycomed Pharma As Farmaceutisk præparat indeholdende N-glycofuroler og N-ethylenglycoler
US5645591A (en) * 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US5206354A (en) 1990-11-23 1993-04-27 American Cyanamid Company Dna sequence encoding active fragment of fibroblast growth factor, hbf-2
SE501217C2 (sv) * 1990-12-06 1994-12-12 Skandigen Ab Cellproliferationsmatris och användning därav
JP3135138B2 (ja) 1990-12-19 2001-02-13 科研製薬株式会社 骨疾患治療剤
US5206023A (en) 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5143662A (en) 1991-02-12 1992-09-01 United States Surgical Corporation Process for preparing particles of bioabsorbable polymer
JPH04282322A (ja) * 1991-03-08 1992-10-07 Denki Kagaku Kogyo Kk 生物活性ペプチド製剤
US5416071A (en) 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
DE4121043A1 (de) * 1991-06-26 1993-01-07 Merck Patent Gmbh Knochenersatzmaterial mit fgf
US5356629A (en) 1991-07-12 1994-10-18 United States Surgical Corporation Composition for effecting bone repair
US5344644A (en) 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release
US5302397A (en) 1991-11-19 1994-04-12 Amsden Brian G Polymer-based drug delivery system
AU667069B2 (en) 1991-12-06 1996-03-07 North Shore University Hospital Research Corporation Method of reducing medical device related infections
US5482929A (en) 1991-12-26 1996-01-09 Kaken Pharmaceutical Co., Ltd. Composition of stabilized fibroblast growth factor
SE469653B (sv) 1992-01-13 1993-08-16 Lucocer Ab Poroest implantat
JPH07503869A (ja) * 1992-02-14 1995-04-27 ボード・オヴ・リージェンツ,ザ・ユニヴァーシティ・オヴ・テキサス・システム 多相生侵食性の移植材料または担体並びにその製造および使用方法
US5348941A (en) 1992-04-01 1994-09-20 Merck & Co., Inc. Stabilizers for fibroblast growth factors
US5318957A (en) 1992-09-02 1994-06-07 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating angiogenesis
US5399352A (en) 1993-04-14 1995-03-21 Emory University Device for local drug delivery and methods for using the same
US5531794A (en) * 1993-09-13 1996-07-02 Asahi Kogaku Kogyo Kabushiki Kaisha Ceramic device providing an environment for the promotion and formation of new bone
EP0881908B1 (en) * 1994-03-08 2004-06-16 Osteosa Inc. Use of fibroblast growth factors to stimulate bone growth
US5769899A (en) * 1994-08-12 1998-06-23 Matrix Biotechnologies, Inc. Cartilage repair unit
US5577792A (en) * 1995-02-21 1996-11-26 Prince Corporation Multiple visor system with aligned pivot axes
US5776193A (en) * 1995-10-16 1998-07-07 Orquest, Inc. Bone grafting matrix
CA2247439A1 (en) * 1996-02-27 1997-09-04 Sankyo Company, Limited Isoxazole derivatives
WO1997032591A1 (en) * 1996-03-05 1997-09-12 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
CA2246747C (en) 1996-03-05 2011-01-04 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
US6221854B1 (en) * 1996-03-05 2001-04-24 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
US6645945B1 (en) * 1996-03-05 2003-11-11 Depuy Acromed, Inc. Method of treating diseased, injured or abnormal cartilage with hyaluronic acid and growth factors
US5942499A (en) * 1996-03-05 1999-08-24 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
KR100236771B1 (ko) * 1997-04-01 2000-02-01 성재갑 히아루론산을 이용한 약물의 서방성 미세입자 제형
IT1288290B1 (it) * 1996-06-21 1998-09-11 Fidia Spa In Amministrazione S Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
JP2001501934A (ja) * 1996-09-30 2001-02-13 チルドレンズ メディカル センター コーポレーション 標的組織にリモデリングするよう有機マトリックスをプログラムするための方法及び組成物
AU6267798A (en) 1997-02-07 1998-08-26 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
US6303585B1 (en) * 1997-07-03 2001-10-16 Orquest, Inc. Cross-linked polysaccharide drug carrier

Similar Documents

Publication Publication Date Title
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
CA2489270A1 (en) A method of treating human skin and a skin care composition for use in such a method
SE9803710D0 (sv) Use of certain drugs for treating nerve root injury
NZ516097A (en) Method of promoting bone growth with hyaluronic acid and growth factors
BR0110420A (pt) Agonistas muscarìnicos
RU2001128504A (ru) Композиции для стимулирования роста
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
CA2594215A1 (en) Sustained-release nanoparticle compositions and methods for using the same
IL158903A0 (en) Use of sulodexide for the treatment of inflammatory bowel disease
WO2004034975A3 (en) Sustained release profile modification
CA2415869A1 (en) Sprayable wound care compositions comprising gellan gum
YU66600A (sh) Farmaceutski preparati koji mogu da budu gelirani
WO2002009702A8 (en) Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
ES2125696T3 (es) Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales.
TW200503689A (en) Pharmaceutical compositions of atorvastatin
RU2009122167A (ru) Композиция для нанесения на кожу или слизистую оболочку
DE69534620D1 (de) Verfahren zur behandlung von augenerkrankungen
WO2014089381A1 (en) Topical preparation for pain relief
WO2003000173A3 (en) Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
WO2006002096A3 (en) Low doses of l-citrulline for treating diseases
EP1908457A1 (en) Composition based on salts of hyaluronic acid for treating epithelial lesions
JP5255451B2 (ja) 組織の修復又は再生用製剤
AU2002333536A1 (en) Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof